Skip to content

Efficacy of a Dedicated Therapeutic Education Program in Patients at High Cardiovascular Risk

Randomized Prospective Trial Evaluating the Efficacy of a Dedicated Therapeutic Education Program on the Blood Pressure and Other Cardiovascular Risk Factors Control in General Practice Patients at High Cardiovascular Risk

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01622400
Enrollment
240
Registered
2012-06-19
Start date
2011-09-30
Completion date
2016-04-30
Last updated
2018-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High Blood Pressure

Keywords

Cardiovascular risk, Therapeutic education, General practice

Brief summary

A dedicated therapeutic education program is an essential tool in the management of hypertension as well as in the control of other cardiovascular risk factors. The purpose of this study is therefore to evaluate the effect of such a therapeutic education program in general practice patients at high cardiovascular risk.

Detailed description

Current guidelines for the prevention of cardiovascular disease recognize the major interest of an optimal control of all cardiovascular risk factors. It includes high blood pressure reduction, dietetic measures (weight loss - control of dyslipidemia and diabetes - regular physical activity), smoking cessation, stress management, … In that way, some authors suggest that it is essential for patients at high risk to have knowledge about their own pathology, medication, and to better understand the real benefit of specific lifestyle behaviors and the importance of blood pressure and glycaemia surveillance … The aim of this randomized controlled trial is to evaluate the efficacy of a dedicated therapeutic education program to control blood pressure and other cardiovascular risk factors in general practice patients at high cardiovascular risk. 250 patients are being enrolled. All patients will receive standard care but only 125 patients (randomized 1 to 1) will receive a structured therapeutic education program.

Interventions

OTHERTherapeutic education HTA Vasc

The intervention program takes place in 3 phases. First, the education team realizes an individual educational diagnosis to define the objectives of the intervention according to each patient's needs. Secondly, patients assist to 3 to 5 group sessions lasting 2 hours with a dedicated nurse focusing on medical therapy explanation and blood pressure self measurement education - and with a dedicated nutritionist focusing on stress management and nutrition program. Patients can also have individual consultations with the dedicated nutritionist. Finally, an individual assessment permits to evaluate the benefits of the program for each patient and to define new objectives.

Sponsors

Association HTA Vasc
CollaboratorOTHER
CRESGE (Centre de Recherches Economiques Sociologiques et de Gestion)
CollaboratorUNKNOWN
CERIM (Centre d'Etudes et de Recherche en Informatique Médicale), P. Devos
CollaboratorUNKNOWN
University Hospital, Lille
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Man or woman of more than 18 years with a health insurance policy * General practice patients who are agree to participate of the program of patient's therapeutic education in Lille (59) or Arras (62) * Written informed consent must be obtained prior to performing any study-specific procedures * Patient at high cardiovascular risk (Patient with a high blood pressure and 3 cardiovascular risk factors and/or Patient with cardiovascular disease)

Exclusion criteria

* Patient unwilling to take part to the therapeutic education program or to the study * Patient not suitable to participate in the therapeutic education program * Patient with dementia * Anticipated survival (due to comorbidities) of less than one year from baseline * Patient with current addiction or current alcohol / drug abuse * Patient with known plans to move to another area of the country * Unable to obtain written informed consent * Patient who are pregnant or lactating * Person without liberty by administrative or judiciary decision

Design outcomes

Primary

MeasureTime frameDescription
High Blood Pressure in 12 months12 monthsPercentage of patients with a blood pressure of 140/90 mmHg or less in 12 months

Secondary

MeasureTime frameDescription
High Blood pressure at 24 months24 monthsPercentage of patients with a blood pressure of 140/90 mmHg or less in 24 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026